NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
Clinical Trials
7 trialsNCT05344625 2024-01-24
KAPTIVATED
Northwell Health
Phase EARLY_PHASE1 Withdrawn
NCT03410446 2022-05-06
Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
University Health Network, Toronto
Phase 2 Completed
NCT03086148 2020-07-07
Ketamine and Postoperative Depressive Symptom-PASSION
Beijing Tiantan Hospital
Phase 2/3 Completed
NCT02442739 2018-11-06
Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT02836288 2018-11-06
Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT01680172 2016-02-29
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
Mayo Clinic
Phase 2 Terminated